世界の皮膚充填剤・ボツリヌス毒素市場予測 2021年-2026年

◆英語タイトル:Global Dermal Fillers and Botulinum Toxin Market Growth 2021-2026
◆商品コード:LPI21JL15188
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月
◆ページ数:163
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥402,600見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥603,900見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥805,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
LP Information社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

LPインフォメーション社の「皮膚充填剤・ボツリヌス毒素の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、皮膚充填剤、ボツリヌス菌毒素など、用途別には、医療用、化粧品用などにセグメント区分してまとめました。皮膚充填剤・ボツリヌス毒素のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・皮膚充填剤・ボツリヌス毒素の世界市場概要(サマリー)
・皮膚充填剤・ボツリヌス毒素の企業別販売量・売上
・皮膚充填剤・ボツリヌス毒素の企業別市場シェア
・皮膚充填剤・ボツリヌス毒素の世界市場規模 2016年-2021年:種類別(皮膚充填剤、ボツリヌス菌毒素)
・皮膚充填剤・ボツリヌス毒素の世界市場規模 2016年-2021年:用途別(医療用、化粧品用)
・皮膚充填剤・ボツリヌス毒素の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・皮膚充填剤・ボツリヌス毒素のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・皮膚充填剤・ボツリヌス毒素のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・皮膚充填剤・ボツリヌス毒素の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・皮膚充填剤・ボツリヌス毒素市場の成長要因・課題・動向
・皮膚充填剤・ボツリヌス毒素の世界市場予測 2021年-2026年
・皮膚充填剤・ボツリヌス毒素の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・皮膚充填剤・ボツリヌス毒素のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・皮膚充填剤・ボツリヌス毒素のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・皮膚充填剤・ボツリヌス毒素の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・皮膚充填剤・ボツリヌス毒素の世界市場予測:種類別(皮膚充填剤、ボツリヌス菌毒素)
・皮膚充填剤・ボツリヌス毒素の世界市場予測:用途別(医療用、化粧品用)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Dermal Fillers and Botulinum Toxin will have significant change from previous year. By the most conservative estimates of global Dermal Fillers and Botulinum Toxin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 10320 million in 2020. Over the next five years the Dermal Fillers and Botulinum Toxin market will register a 14.7% CAGR in terms of revenue, the global market size will reach US$ 17880 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Fillers and Botulinum Toxin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Dermal Fillers
Botulinum Toxin
The proportion of dermal fillers in 2019 is about 52%.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Medical
Cosmetic
The most of dermal fillers and botulinum toxin is used in cosmetic, and the market share of that is about 75.5% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermal Fillers and Botulinum Toxin Consumption 2016-2026
2.1.2 Dermal Fillers and Botulinum Toxin Consumption CAGR by Region
2.2 Dermal Fillers and Botulinum Toxin Segment by Type
2.2.1 Dermal Fillers
2.2.2 Botulinum Toxin
2.3 Dermal Fillers and Botulinum Toxin Sales by Type
2.3.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
2.3.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dermal Fillers and Botulinum Toxin Sale Price by Type (2016-2021)
2.4 Dermal Fillers and Botulinum Toxin Segment by Application
2.4.1 Medical
2.4.2 Cosmetic
2.5 Dermal Fillers and Botulinum Toxin Sales by Application
2.5.1 Global Dermal Fillers and Botulinum Toxin Sale Market Share by Application (2016-2021)
2.5.2 Global Dermal Fillers and Botulinum Toxin Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dermal Fillers and Botulinum Toxin Sale Price by Application (2016-2021)

3 Global Dermal Fillers and Botulinum Toxin by Company
3.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Company
3.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Company (2019-2021)
3.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2019-2021)
3.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company
3.2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Company (2019-2021)
3.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2019-2021)
3.3 Global Dermal Fillers and Botulinum Toxin Sale Price by Company
3.4 Global Manufacturers Dermal Fillers and Botulinum Toxin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dermal Fillers and Botulinum Toxin Product Location Distribution
3.4.2 Players Dermal Fillers and Botulinum Toxin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Dermal Fillers and Botulinum Toxin by Region
4.1 Global Dermal Fillers and Botulinum Toxin by Region
4.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Region
4.1.2 Global Dermal Fillers and Botulinum Toxin Revenue by Region
4.2 Americas Dermal Fillers and Botulinum Toxin Sales Growth
4.3 APAC Dermal Fillers and Botulinum Toxin Sales Growth
4.4 Europe Dermal Fillers and Botulinum Toxin Sales Growth
4.5 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Growth

5 Americas
5.1 Americas Dermal Fillers and Botulinum Toxin Sales by Country
5.1.1 Americas Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
5.1.2 Americas Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
5.2 Americas Dermal Fillers and Botulinum Toxin Sales by Type
5.3 Americas Dermal Fillers and Botulinum Toxin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Dermal Fillers and Botulinum Toxin Sales by Region
6.1.1 APAC Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021)
6.1.2 APAC Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021)
6.2 APAC Dermal Fillers and Botulinum Toxin Sales by Type
6.3 APAC Dermal Fillers and Botulinum Toxin Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Dermal Fillers and Botulinum Toxin by Country
7.1.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
7.1.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
7.2 Europe Dermal Fillers and Botulinum Toxin Sales by Type
7.3 Europe Dermal Fillers and Botulinum Toxin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Dermal Fillers and Botulinum Toxin by Country
8.1.1 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021)
8.2 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Type
8.3 Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dermal Fillers and Botulinum Toxin Distributors
10.3 Dermal Fillers and Botulinum Toxin Customer

11 Global Dermal Fillers and Botulinum Toxin Market Forecast
11.1 Global Dermal Fillers and Botulinum Toxin Forecast by Region
11.1.1 Global Dermal Fillers and Botulinum Toxin Forecast by Regions (2021-2026)
11.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Dermal Fillers and Botulinum Toxin Forecast by Type
11.7 Global Dermal Fillers and Botulinum Toxin Forecast by Application

12 Key Players Analysis
12.1 Allergan
12.1.1 Allergan Company Information
12.1.2 Allergan Dermal Fillers and Botulinum Toxin Product Offered
12.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Allergan Main Business Overview
12.1.5 Allergan Latest Developments
12.2 Galderma
12.2.1 Galderma Company Information
12.2.2 Galderma Dermal Fillers and Botulinum Toxin Product Offered
12.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Galderma Main Business Overview
12.2.5 Galderma Latest Developments
12.3 LG Life Science
12.3.1 LG Life Science Company Information
12.3.2 LG Life Science Dermal Fillers and Botulinum Toxin Product Offered
12.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 LG Life Science Main Business Overview
12.3.5 LG Life Science Latest Developments
12.4 Merz
12.4.1 Merz Company Information
12.4.2 Merz Dermal Fillers and Botulinum Toxin Product Offered
12.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merz Main Business Overview
12.4.5 Merz Latest Developments
12.5 Medytox
12.5.1 Medytox Company Information
12.5.2 Medytox Dermal Fillers and Botulinum Toxin Product Offered
12.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Medytox Main Business Overview
12.5.5 Medytox Latest Developments
12.6 Bloomage
12.6.1 Bloomage Company Information
12.6.2 Bloomage Dermal Fillers and Botulinum Toxin Product Offered
12.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Bloomage Main Business Overview
12.6.5 Bloomage Latest Developments
12.7 Bohus BioTech
12.7.1 Bohus BioTech Company Information
12.7.2 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Offered
12.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Bohus BioTech Main Business Overview
12.7.5 Bohus BioTech Latest Developments
12.8 Sinclair Pharma
12.8.1 Sinclair Pharma Company Information
12.8.2 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Offered
12.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sinclair Pharma Main Business Overview
12.8.5 Sinclair Pharma Latest Developments
12.9 IMEIK
12.9.1 IMEIK Company Information
12.9.2 IMEIK Dermal Fillers and Botulinum Toxin Product Offered
12.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 IMEIK Main Business Overview
12.9.5 IMEIK Latest Developments
12.10 Suneva Medical
12.10.1 Suneva Medical Company Information
12.10.2 Suneva Medical Dermal Fillers and Botulinum Toxin Product Offered
12.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Suneva Medical Main Business Overview
12.10.5 Suneva Medical Latest Developments
12.11 Teoxane
12.11.1 Teoxane Company Information
12.11.2 Teoxane Dermal Fillers and Botulinum Toxin Product Offered
12.11.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Teoxane Main Business Overview
12.11.5 Teoxane Latest Developments
12.12 Luminera
12.12.1 Luminera Company Information
12.12.2 Luminera Dermal Fillers and Botulinum Toxin Product Offered
12.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Luminera Main Business Overview
12.12.5 Luminera Latest Developments
12.13 SciVision Biotech
12.13.1 SciVision Biotech Company Information
12.13.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Offered
12.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 SciVision Biotech Main Business Overview
12.13.5 SciVision Biotech Latest Developments
12.14 Haohai Bio
12.14.1 Haohai Bio Company Information
12.14.2 Haohai Bio Dermal Fillers and Botulinum Toxin Product Offered
12.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Haohai Bio Main Business Overview
12.14.5 Haohai Bio Latest Developments
12.15 Ipsen
12.15.1 Ipsen Company Information
12.15.2 Ipsen Dermal Fillers and Botulinum Toxin Product Offered
12.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Ipsen Main Business Overview
12.15.5 Ipsen Latest Developments
12.16 LIBP
12.16.1 LIBP Company Information
12.16.2 LIBP Dermal Fillers and Botulinum Toxin Product Offered
12.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 LIBP Main Business Overview
12.16.5 LIBP Latest Developments
12.17 US World Meds
12.17.1 US World Meds Company Information
12.17.2 US World Meds Dermal Fillers and Botulinum Toxin Product Offered
12.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 US World Meds Main Business Overview
12.17.5 US World Meds Latest Developments
12.18 Hugel
12.18.1 Hugel Company Information
12.18.2 Hugel Dermal Fillers and Botulinum Toxin Product Offered
12.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Hugel Main Business Overview
12.18.5 Hugel Latest Developments
12.19 Daewoong
12.19.1 Daewoong Company Information
12.19.2 Daewoong Dermal Fillers and Botulinum Toxin Product Offered
12.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Daewoong Main Business Overview
12.19.5 Daewoong Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Dermal Fillers and Botulinum Toxin Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Dermal Fillers
Table 3. Major Players of Botulinum Toxin
Table 4. Global Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 6. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & ($ million)
Table 7. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2021)
Table 8. Global Dermal Fillers and Botulinum Toxin Sale Price by Type (2016-2021)
Table 9. Global Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 10. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 11. Global Dermal Fillers and Botulinum Toxin Value by Application (2016-2021)
Table 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2021)
Table 13. Global Dermal Fillers and Botulinum Toxin Sale Price by Application (2016-2021)
Table 14. Global Dermal Fillers and Botulinum Toxin Sales by Company (2019-2021) & (K Units)
Table 15. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2019-2021)
Table 16. Global Dermal Fillers and Botulinum Toxin Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2019-2021)
Table 18. Global Dermal Fillers and Botulinum Toxin Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Dermal Fillers and Botulinum Toxin Producing Area Distribution and Sales Area
Table 20. Players Dermal Fillers and Botulinum Toxin Products Offered
Table 21. Dermal Fillers and Botulinum Toxin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) (K Units)
Table 25. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 26. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Table 28. Americas Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 29. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 30. Americas Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 32. Americas Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 33. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 34. Americas Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 35. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 36. APAC Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 37. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 38. APAC Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Table 40. APAC Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 41. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 42. APAC Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 43. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 44. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 45. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 46. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 48. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 49. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 50. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 51. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Dermal Fillers and Botulinum Toxin
Table 61. Key Application and Potential Industries of Dermal Fillers and Botulinum Toxin
Table 62. Key Challenges of Dermal Fillers and Botulinum Toxin
Table 63. Key Trends of Dermal Fillers and Botulinum Toxin
Table 64. Dermal Fillers and Botulinum Toxin Distributors List
Table 65. Dermal Fillers and Botulinum Toxin Customer List
Table 66. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Dermal Fillers and Botulinum Toxin Consumption Market Forecast by Region
Table 68. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Dermal Fillers and Botulinum Toxin Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Dermal Fillers and Botulinum Toxin Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Dermal Fillers and Botulinum Toxin Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Dermal Fillers and Botulinum Toxin Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Application (2021-2026)
Table 86. Allergan Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 87. Allergan Dermal Fillers and Botulinum Toxin Product Offered
Table 88. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Allergan Main Business
Table 90. Allergan Latest Developments
Table 91. Galderma Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 92. Galderma Dermal Fillers and Botulinum Toxin Product Offered
Table 93. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Galderma Main Business
Table 95. Galderma Latest Developments
Table 96. LG Life Science Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 97. LG Life Science Dermal Fillers and Botulinum Toxin Product Offered
Table 98. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. LG Life Science Main Business
Table 100. LG Life Science Latest Developments
Table 101. Merz Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 102. Merz Dermal Fillers and Botulinum Toxin Product Offered
Table 103. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Merz Main Business
Table 105. Merz Latest Developments
Table 106. Medytox Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 107. Medytox Dermal Fillers and Botulinum Toxin Product Offered
Table 108. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Medytox Main Business
Table 110. Medytox Latest Developments
Table 111. Bloomage Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 112. Bloomage Dermal Fillers and Botulinum Toxin Product Offered
Table 113. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Bloomage Main Business
Table 115. Bloomage Latest Developments
Table 116. Bohus BioTech Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 117. Bohus BioTech Dermal Fillers and Botulinum Toxin Product Offered
Table 118. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Bohus BioTech Main Business
Table 120. Bohus BioTech Latest Developments
Table 121. Sinclair Pharma Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 122. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Offered
Table 123. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Sinclair Pharma Main Business
Table 125. Sinclair Pharma Latest Developments
Table 126. IMEIK Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 127. IMEIK Dermal Fillers and Botulinum Toxin Product Offered
Table 128. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. IMEIK Main Business
Table 130. IMEIK Latest Developments
Table 131. Suneva Medical Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 132. Suneva Medical Dermal Fillers and Botulinum Toxin Product Offered
Table 133. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Suneva Medical Main Business
Table 135. Suneva Medical Latest Developments
Table 136. Teoxane Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 137. Teoxane Dermal Fillers and Botulinum Toxin Product Offered
Table 138. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 139. Teoxane Main Business
Table 140. Teoxane Latest Developments
Table 141. Luminera Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 142. Luminera Dermal Fillers and Botulinum Toxin Product Offered
Table 143. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 144. Luminera Main Business
Table 145. Luminera Latest Developments
Table 146. SciVision Biotech Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 147. SciVision Biotech Dermal Fillers and Botulinum Toxin Product Offered
Table 148. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 149. SciVision Biotech Main Business
Table 150. SciVision Biotech Latest Developments
Table 151. Haohai Bio Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 152. Haohai Bio Dermal Fillers and Botulinum Toxin Product Offered
Table 153. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 154. Haohai Bio Main Business
Table 155. Haohai Bio Latest Developments
Table 156. Ipsen Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 157. Ipsen Dermal Fillers and Botulinum Toxin Product Offered
Table 158. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 159. Ipsen Main Business
Table 160. Ipsen Latest Developments
Table 161. LIBP Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 162. LIBP Dermal Fillers and Botulinum Toxin Product Offered
Table 163. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 164. LIBP Main Business
Table 165. LIBP Latest Developments
Table 166. US World Meds Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 167. US World Meds Dermal Fillers and Botulinum Toxin Product Offered
Table 168. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 169. US World Meds Main Business
Table 170. US World Meds Latest Developments
Table 171. Hugel Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 172. Hugel Dermal Fillers and Botulinum Toxin Product Offered
Table 173. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 174. Hugel Main Business
Table 175. Hugel Latest Developments
Table 176. Daewoong Basic Information, Dermal Fillers and Botulinum Toxin Manufacturing Base, Sales Area and Its Competitors
Table 177. Daewoong Dermal Fillers and Botulinum Toxin Product Offered
Table 178. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 179. Daewoong Main Business
Table 180. Daewoong Latest Developments
List of Figures
Figure 1. Picture of Dermal Fillers and Botulinum Toxin
Figure 2. Dermal Fillers and Botulinum Toxin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dermal Fillers and Botulinum Toxin Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dermal Fillers and Botulinum Toxin Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Dermal Fillers
Figure 10. Product Picture of Botulinum Toxin
Figure 11. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2021)
Figure 13. Dermal Fillers and Botulinum Toxin Consumed in Medical
Figure 14. Global Dermal Fillers and Botulinum Toxin Market: Medical (2016-2021) & (K Units)
Figure 15. Dermal Fillers and Botulinum Toxin Consumed in Cosmetic
Figure 16. Global Dermal Fillers and Botulinum Toxin Market: Cosmetic (2016-2021) & (K Units)
Figure 17. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Figure 18. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application in 2020
Figure 19. Dermal Fillers and Botulinum Toxin Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Company in 2020
Figure 21. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Regions (2016-2021)
Figure 22. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region in 2020
Figure 23. Americas Dermal Fillers and Botulinum Toxin Sales 2016-2021 (K Units)
Figure 24. Americas Dermal Fillers and Botulinum Toxin Revenue 2016-2021 ($ Millions)
Figure 25. APAC Dermal Fillers and Botulinum Toxin Sales 2016-2021 (K Units)
Figure 26. APAC Dermal Fillers and Botulinum Toxin Revenue 2016-2021 ($ Millions)
Figure 27. Europe Dermal Fillers and Botulinum Toxin Sales 2016-2021 (K Units)
Figure 28. Europe Dermal Fillers and Botulinum Toxin Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue 2016-2021 ($ Millions)
Figure 31. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 32. Americas Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 33. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 34. Americas Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 35. United States Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Region in 2020
Figure 40. APAC Dermal Fillers and Botulinum Toxin Revenue Market Share by Regions in 2020
Figure 41. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 42. APAC Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 43. China Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 50. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 51. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 52. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 53. Germany Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 62. Egypt Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Dermal Fillers and Botulinum Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の皮膚充填剤・ボツリヌス毒素市場予測 2021年-2026年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆